Physical & Computational Genomics Division 2021

 

Chang, Tien-Hsien

  • Yeh, F.-L., Chang, S.-L., Ahmed, G. R., Liu, H.-I, Tung, L., Yeh, C.-S., Lanier, L. S., Maeder, C., Lin, C.-M., Tsai, S.-C., Hsiao, W.-Y., Chang, W.-H., and Chang, T.-H.*, 2021, “Activation of Prp28 ATPase by phosphorylated Npl3 at a critical step of spliceosome remodeling”, NATURE COMMUNICATIONS, 12, 3082. (SCIE)
  • Tsai, N.-C., Hsu, T.-S., Kuo, S.-C., Kao, C.-T., Hung, T.-H., Lin, D.-G., Yeh, C.-S., Chu, C.-C., Lin, J.-S., Lin, H.-H.; Ko, C.-Y., Chang, T.-H.*, Su, J.-C.*, and Lin, Y.-C.*, 2021, “Large-scale data analysis for robotic yeast one-hybrid platforms and multi-disciplinary studies using GateMultiplex”, BMC Biology, 19, 214. (SCIE)

Yang, An-Suei

  • Ko YA, Yu YH, Wu YF, Tseng YC, Chen CL, Goh KS, Liao HY, Chen TH, Cheng TR, Yang AS, Wong CH, Ma C, Lin KI, 2021, “A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cells.”, PLoS pathogens, 17(8), e1009724. (SCIE)
  • Hsu HJ, Tung CP, Yu CM, Chen CY, Chen HS, Huang YC, Tsai PH, Lin SI, Peng HP, Chiu YK, Tsou YL, Kuo WY, Jian JW, Hung FH, Hsieh CY, Hsiao M, Chuang SS, Shen CN, Wang YA, Yang AS*, 2021, “Eradicating mesothelin-positive human gastric and pancreatic tumors in xenograft models with optimized anti-mesothelin antibody-drug conjugates from synthetic antibody libraries.”, Scientific reports, 11(1), 15430. (SCIE)
  • Tsai Tsung-Yu, Huang Ming-Ting, Sung Pei-Shan, Peng Cheng-Yuan, Tao Mi-Hua, Yang Hwai-I, Chang Wei-Chiao, Yang An-Suei, Yu Chung-Ming, Lin Ya-Ping, Bau Ching-Yu, Huang Chih-Jen, Pan Mei-Hung, Wu Chung-Yi, Hsiao Chwan-Deng, Yeh Yi-Hung, Duan Shiteng, Paulson James C, Hsieh Shie-Liang, 2021, “SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection”, Journal of Clinical Investigation, 131(11), e141965. (SCIE)
  • Huang YL, Huang MT, Sung PS, Chou TY, Yang RB, Yang AS, Yu CM, Hsu YW, Chang WC, Hsieh SL, 2021, “Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection.”, Communications biology, 4(1), 229. (SCIE)
  • Kuo WC, Lee CC, Chang YW, Pang W, Chen HS, Hou SC, Lo SY, Yang AS, Wang AH*, 2021, “Structure-based Development of Human Interleukin-1beta-Specific Antibody That Simultaneously Inhibits Binding to Both IL-1RI and IL-1RAcP.”, Journal of molecular biology, 433(4), 166766. (SCIE)

Publications